Organization | Wellcome Trust

Wellcome Trust Report issue

Foundation Phase 1 Phase 2 Phase 3 Phase 4

Founded: London United Kingdom (1936)

Organization Overview

First Clinical Trial

1982

NCT00294580

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

KEMRI/Welcome Trust Research Programme,Kilifi, Kenya | KEMRI-Wellcome Trust | KEMRI-Wellcome Trust Collaborative Research Program | Malawi-Liverpool-Wellcome Trust Clinical Research Programme | Wellcome | Wellcome Trust | Wellcome Trust DBT India Alliance | Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge | Wellcome Trust Sanger Institute | Wellcome Trust Sanger Institute, UK | Wellcome Trust United Kingdom | WTCRF Birmingham

Active Ingredients

Drugs in Phase 4 Trials (25)

10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)

acetazolamide (diamox) (1 trial)

amodiaquine (camoquin) (3 trials)

artemether (2 trials)

artesunate (6 trials)

azithromycin (zithromax) (7 trials)

cefixime (suprax) (1 trial)

chloroquine (4 trials)

coartem (2 trials)

dihydroqinghaosu (4 trials)

dtap (2 trials)

hepatitis a vaccine, inactivated (vaqta) (2 trials)

human rotavirus, live attenuated (Rotarix) (1 trial)

isoniazid (nydrazid) (3 trials)

live attenuated chimeric japanese encephalitis vaccine (1 trial)

lumefantrine (Coartem) (3 trials)

maloprim (1 trial)

menafrivac (1 trial)

monovalent group a meningococcal vaccine (2 trials)

multi-valent pneumococcal conjugate vaccine (1 trial)

piperaquinoline (4 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

pneumococcal 7-valent conjugate vaccine (prevnar) (1 trial)

typhoid vi polysaccharide vaccine (Typhim Vi) (4 trials)

yellow fever vaccine 17d strain (1 trial)

Drugs in Phase 3 Trials (42)

acetylsalicylic acid (aspirin) (2 trials)

albendazole (Albenza) (2 trials)

amoxicillin (1 trial)

ampicillin (2 trials)

as01e (1 trial)

atenolol (tenormin) (1 trial)

benzylpenicilloyl polylysine (pre-pen) (1 trial)

beractant (survanta) (1 trial)

cadisurf (1 trial)

ceftriaxone (rocephin) (1 trial)

cmv-specific t-cells (1 trial)

cotrimoxazole (1 trial)

COVID-19 convalescent plasma (1 trial)

dihydroartemisinin (1 trial)

eurartesim (1 trial)

fansidar (1 trial)

fluconazole (diflucan) (1 trial)

gentamicin (garamycin) (2 trials)

hydroxychloroquine (plaquenil) (3 trials)

inactivated rabies vaccine (Imovax) (2 trials)

lopinavir (Kaletra) (1 trial)

matrix-m1 (3 trials)

pancrelipase (creon) (1 trial)

piperaquine (2 trials)

primaquine (3 trials)

procaine benzylpenicillin (novocaine) (1 trial)

pyrimethamine (daraprim) (4 trials)

raltegravir (isentress) (1 trial)

ramipril (altace) (1 trial)

ritonavir (Norvir) (1 trial)

rts,s (1 trial)

sertraline (zoloft) (1 trial)

simvastatin (zocor) (2 trials)

sulfadoxine (4 trials)

thiazide (1 trial)

tocilizumab (actemra) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

typhoid vaccine (1 trial)

ursodeoxycholic acid (1 trial)

valganciclovir (valcyte) (1 trial)

vitamin d3 (2 trials)

Drugs in Phase 2 Trials (42)

13-cis-retinoic Acid (1 trial)

adalimumab (humira) (1 trial)

aldesleukin (proleukin) (2 trials)

anti-staphylococcus bacteriophage therapy (1 trial)

arginine (2 trials)

azd7295 (1 trial)

bacille calmette-guerin (2 trials)

chad63-kh (1 trial)

cilostazol (pletal) (1 trial)

cipargamin (1 trial)

clofazimine (lamprene) (1 trial)

dolutegravir (tivicay) (1 trial)

ferric sulfate (1 trial)

fish oil (Omegavan) (1 trial)

fosfomycin (monurol) (1 trial)

fp9 me-trap (1 trial)

fp9-pp (2 trials)

gla-se (1 trial)

grazax (1 trial)

guanfacine (tenex) (1 trial)

linseed oil (1 trial)

liraglutide (victoza) (1 trial)

m10zh09 vaccine (1 trial)

mefloquine (lariam) (1 trial)

menacwy conjugate vaccine (1 trial)

mva-np (2 trials)

mva-pp (2 trials)

oseltamivir (tamiflu) (1 trial)

pp1420 (2 trials)

proguanil (1 trial)

ridinilazole (1 trial)

rv3-bb (1 trial)

sf2a-tt15 (1 trial)

shigella conjugate vaccines (1 trial)

sildenafil (viagra) (1 trial)

sodium chloride (2 trials)

tofacitinib (xeljanz) (1 trial)

ty21a (1 trial)

valaciclovir (Valtrex) (1 trial)

vancomycin (Vancocin) (1 trial)

vsv-zebov (2 trials)

Drugs in Phase 1 Trials (21)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

cad3-zebov (2 trials)

cct3833 (1 trial)

chadox1.thivconsv1 (1 trial)

cn54gp140 (2 trials)

deuterated glucose (1 trial)

docetaxel (taxotere) (1 trial)

flexyn2a (1 trial)

gla-af (2 trials)

lhf-535 (1 trial)

menpf-1 (1 trial)

mva-bn-filo (2 trials)

mva-c (1 trial)

mva.thivconsv3 (1 trial)

mva.thivconsv4 (1 trial)

naltrexone (revia) (2 trials)

plasmodium falciparum sporozoite (1 trial)

plg0206 (1 trial)

rvsvdelta-zebov-gp (1 trial)

trl1068 (1 trial)

ue2343 (1 trial)

Drugs in Other Trials (18)

alirocumab (praluent) (1 trial)

atorvastatin (lipitor) (1 trial)

bexsero (1 trial)

ceftazidime (fortaz) (1 trial)

coartemether (1 trial)

cocoa butter (1 trial)

efavirenz (sustiva) (1 trial)

ergocalciferol (drisdol) (1 trial)

evolocumab (repatha) (1 trial)

ibuprofen (motrin) (1 trial)

inactivated influenza vaccine (1 trial)

lamivudine (epivir) (1 trial)

meropenem (merrem) (1 trial)

seasonal influenza and pneumococcal polysaccharide vaccines (1 trial)

sufonylurea (1 trial)

sulfasalazine (azulfidine) (1 trial)

vitamin c (1 trial)

zidovudine (retrovir) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 3)

Altitude Sickness (Phase 4)

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 2)

Anemia, Sickle Cell (Phase 3)

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (Phase 2)

Cardiovascular Diseases (Phase 3)

Cerebral Small Vessel Diseases (Phase 2)

Cerebrovascular Disorders (Phase 2)

Child Nutrition Disorders (Phase 3)

Clostridium Infections (Phase 2)

Communicable Diseases (Phase 4)

Coronavirus Infections (Phase 3)

Cryptosporidiosis (Phase 2)

Cytomegalovirus Infections (Phase 3)

Depression (Phase 2)

Depressive Disorder (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Diabetic Foot (Phase 2)

Diarrhea (Phase 4)

Dupuytren Contracture (Phase 2)

Dysentery, Bacillary (Phase 2)

Encephalitis (Phase 4)

Encephalitis, Japanese (Phase 4)

Fatty Liver (Phase 2)

Fever (Phase 4)

Foot Ulcer (Phase 2)

Glaucoma (Phase 1)

Hemorrhagic Fever, Ebola (Phase 1)

Hemorrhagic Fevers, Viral (Phase 1)

Hepatitis (Phase 2)

Hepatitis C (Phase 2)

Hepatitis C, Chronic (Phase 2)

HIV Infections (Phase 3)

Infections (Phase 4)

Inflammation (Phase 2)

Influenza, Human (Phase 2)

Influenza in Birds (Phase 2)

Latent Tuberculosis (Phase 4)

Leishmaniasis (Phase 2)

Leishmaniasis, Visceral (Phase 2)

Lung Diseases (Phase 3)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Malaria, Vivax (Phase 4)

Malnutrition (Phase 3)

Melanoma (Phase 1)

Meningitis (Phase 4)

Meningitis, Cryptococcal (Phase 3)

Meningitis, Fungal (Phase 3)

Meningococcal Infections (Phase 1)

Neonatal Sepsis (Phase 2)

Neuroblastoma (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Obesity (Phase 2)

Ocular Hypertension (Phase 1)

Paratyphoid Fever (Phase 4)

Perceptual Disorders (Phase 2)

Pneumococcal Infections (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Pneumococcal (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Rhinitis (Phase 2)

Rhinitis, Allergic (Phase 2)

Rotavirus Infections (Phase 2)

Sepsis (Phase 2)

Severe Acute Malnutrition (Phase 2)

Severe Acute Respiratory Syndrome (Phase 3)

Stroke (Phase 2)

Syndrome (Phase 3)

Toxemia (Phase 2)

Tuberculosis (Phase 4)

Tuberculosis, Pulmonary (Phase 2)

Typhoid Fever (Phase 4)

Vasculitis (Phase 2)

Virus Diseases (Phase 1)

Vitamin D Deficiency (Phase 3)

Yellow Fever (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 126
# of Trial APIs: 148